{"id":"W7108468115","doi":"10.1182/blood-2025-5102","title":"First report of the GIMEMA INO-first multicenter observational study analyzing infective and non-infective complications in patients with relapsed or refractory B-cell acute lymphoblastic leukemia treated with inotuzumab ozogamicin.","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"University Hospital Foundation","funders":"","keywords":"Refractory (planetary science); Observational study; Adverse effect; Salvage therapy; Clinical trial; Lymphoblastic Leukemia; Bone marrow; Leukemia; Toxicity","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003247841,0.0005558199,0.0009466503,0.0007740061,0.0005689673,0.000954628,0.0006549381,0.0006940693,0.002083265],"category_scores_gemma":[0.006478772,0.0003664652,0.001014847,0.001220709,0.000286537,0.0006646253,0.0009935725,0.0007822705,0.0004410502],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006215752,"about_ca_system_score_gemma":0.0008082457,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001574767,"about_ca_topic_score_gemma":0.002114436,"domain_scores_codex":[0.9972997,0.001173227,0.0003702584,0.0005356312,0.0004357529,0.0001854645],"domain_scores_gemma":[0.9906488,0.00134262,0.005476415,0.00107372,0.0006671861,0.0007912339],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.006694335,0.0004939521,0.9832518,0.000423099,0.001325481,0.0002293417,0.000139726,0.00006752404,0.0004332187,0.00009347359,0.002428142,0.004419846],"study_design_scores_gemma":[0.001401627,0.003214668,0.9885339,0.000140783,0.0009894737,0.0008053874,0.0001921877,0.0002048127,0.0002725392,0.00007332965,0.004144611,0.00002660988],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9720703,0.005707145,0.0006871229,0.0002644559,0.00008183013,0.001080346,0.01788805,0.00003007957,0.002190749],"genre_scores_gemma":[0.9774932,0.001020455,0.0009022293,0.0004757108,0.000235348,0.001587753,0.01781235,0.00002218465,0.000450684],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003247841,"threshold_uncertainty_score":0.01717645,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01334746923335991,"score_gpt":0.266292957780445,"score_spread":0.2529454885470852,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}